Form 8-K - Current report:
SEC Accession No. 0001193125-24-032780
Filing Date
2024-02-13
Accepted
2024-02-13 06:07:00
Documents
14
Period of Report
2024-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d780650d8k.htm   iXBRL 8-K 26459
  Complete submission text file 0001193125-24-032780.txt   153008

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sttk-20240209.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sttk-20240209_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sttk-20240209_pre.xml EX-101.PRE 11717
15 EXTRACTED XBRL INSTANCE DOCUMENT d780650d8k_htm.xml XML 3762
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 24622460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)